Lutein in Children: What Changed?
Six-month trial evaluates choroidal thickness and axial length
-
By
-
Jess Allerton
-
February 16, 2026
-
Clinical Scorecard: Lutein in Children: What Changed?
At a Glance
| Category | Detail |
|---|
| Condition | Myopia progression in children |
| Key Mechanisms | Lutein ester supplementation affects subfoveal choroidal thickness (CT) |
| Target Population | School-age children aged 8 to 12 years |
| Care Setting | Clinical trial setting |
Key Highlights
- Lutein ester supplementation preserved subfoveal choroidal thickness over six months.
- No significant changes in axial elongation or refractive progression were observed.
- The study involved 180 children in a double-blind, randomized controlled trial.
- Statistically significant difference in CT between lutein and placebo groups.
- Thinner subfoveal CT at baseline associated with longer axial length and more myopic refractive error.
Guideline-Based Recommendations
Diagnosis
- Monitor subfoveal choroidal thickness as a potential indicator of myopia progression.
Management
- Consider lutein ester supplementation for preserving choroidal thickness.
Monitoring & Follow-up
- Evaluate changes in choroidal thickness using OCT imaging.
Risks
- No adverse events reported during the trial.
Patient & Prescribing Data
Children aged 8 to 12 years with myopia concerns
Lutein ester may help maintain choroidal thickness but does not affect refractive outcomes.
Clinical Best Practices
- Use quantitative OCT biomarkers as endpoints in pediatric vision research.
- Differentiate between structural changes and clinically meaningful refractive outcomes.
References
